TARBP2 and hepatocellular carcinoma: Moreover, the expression of TARBP2 was positively associated with serum HDL-C and negatively associated with serum glucose (Figures S3A–D), indicating TARBP2 might be involved in the disorders of glucose and lipids caused by liver dysfunction in HCC patients.